Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Clues to early detection of bipolar disorders in high-risk children

  • Defect responsible for memory impairment in aging found

  • Family based interpersonal psychotherapy for depressed preadolescents is more effective than child-centered therapy

  • Losing a spouse often too hastily linked to depression

  • People use handshakes to sniff each other out

  • BPA exposure linked to autism spectrum disorder, study reports

  • BPA exposure linked to autism spectrum disorder

  • One step closer to defeating Alzheimer's disease

  • Cerebral blood flow as a possible marker for concussion outcomes

  • Survey of teen dating violence among US high school students

  •